Table 4.
VDI | % | CDA | % |
---|---|---|---|
Nasal blockage/crusting | 22.3 | Chronic rhinitis/crusting | 26.6 |
Peripheral neuropathy | 21.9 | Hypertension* | 21.6 |
Hearing loss | 19.1 | Sensory neuropathy† | 21.6 |
Hypertension | 16.6 | Proteinuria <3 g/24 h | 17.6 |
Proteinuria | 16.6 | Easy bruising | 15.8 |
GFR<50% | 15.1 | Weight gain >10 lbs/4 kg | 14.8 |
Osteoporosis | 11.9 | Conductive hearing loss | 13.7 |
Chronic sinusitis | 11.5 | GFR<50% | 13.3 |
Nasal bridge collapse | 9.7 | Chronic kidney disease | 12.6 |
Cataract | 9.0 | Osteoporosis | 12.6 |
This includes patients with prehypertension, or stage 1 or stage 2 hypertension.
Includes patients with mild, moderate or severe sensory neuropathy.
CDA, Combined Damage Assessment Index; GFR, glomerular filtration rate; VDI, Vasculitis Damage Index.